Document is current
Any future updates will be listed below
-
Authors
Härtlova, Anetta
Herbst, Susanne
Peltier, Julien
Rodgers, Angela
Bilkei‐Gorzo, Orsolya
Fearns, Antony
Dill, Brian D
Lee, Heyne
Flynn, Rowan
Cowley, Sally A https://orcid.org/0000-0003-0297-6675
Davies, Paul
Lewis, Patrick A
Ganley, Ian G https://orcid.org/0000-0003-1481-9407
Martinez, Jennifer
Alessi, Dario R https://orcid.org/0000-0002-2140-9185
Reith, Alastair D
Trost, Matthias https://orcid.org/0000-0002-5732-700X
Gutierrez, Maximiliano G https://orcid.org/0000-0003-3199-0337
-
Funding
Funding for this research was provided by:
Wellcome Trust (FC001092)
Wellcome Trust (WTISSF121302)
Oxford Martin School (LC0910‐004)
Innovative Medicines Initiative Joint Undertaking (115439)
Francis Crick Institute (FC001092)
RCUK | Medical Research Council (MR/N026004/1)
RCUK | Medical Research Council (MR/L010933/1)
RCUK | Medical Research Council (MC_UU_12016/5)
RCUK | Medical Research Council (MC_UP_1202/11)
- License Information
-
More Information
Article History
Received: 21 November 2017
Revised: 5 April 2018
Accepted: 24 April 2018
First Online: 22 May 2018
Conflict of interest
: ADR is an employee of GlaxoSmithKline, a global healthcare company that may conceivably benefit financially through this publication.
